AbbVie, Inc. (ABBV)

205.03 -1.08 (-0.52%) USD  |  NYSE  |  May 06, 16:00
204.85 -0.18 (-0.09%) Pre-Market: 07:02
More

AbbVie SG&A Expense (TTM) : 14.30B for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ABBV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.965B
Biogen, Inc. 2.468B
Gilead Sciences, Inc. 8.398B
Johnson & Johnson 24.60B
Regeneron Pharmaceuticals, Inc. 2.715B